- Child Car Seat Safety Tip: Skip Puffy Winter Coats
- UK Prime Minister Says British COVID Variant May Be More Deadly
- FDA Approves First Once-a-Month HIV Therapy
- Half of Americans Still Not Wearing Masks When Out in Public: Poll
- For Maximum Effectiveness, De-Stress and Get Healthy Before Your COVID Shot
- AHA News: Anxiety Is Linked With Smoking – But How Is Still Hazy
- Biden Warns of 500,000 COVID Deaths by February
- Health Highlights: Jan. 22, 2021
- For Rising Number of People, Obesity Is a Literal Headache
- Even When Cancer Is in Remission, Patients’ Risks of Severe COVID Rise
New Weapon May Help Battle Bird Flu
THURSDAY, Dec. 24Based on findings in animals, researchers are reporting that a new compound may be a better choice for treating bird flu — also known as avian influenza (H5N1) — than the antiviral Tamiflu.
“H5N1 virus is so pathogenic even Tamiflu doesn’t protect all the infected animals. This compound works much better, even three days after infection,” study senior author Yoshihiro Kawaoka, a University of Wisconsin-Madison virologist, said in a university news release.
The researchers tested the compound in mice and found that it was effective against H5N1, seasonal flu and the H1N1 virus. But tests in humans aren’t complete: the third phase of testing, in Japan, has yet to begin.
The compound, known as T-705, could give doctors a new weapon against strains of flu that are resistant to Tamiflu, the study authors noted.
The findings are published online in this week’s issue of the Proceedings of the National Academy of Sciences.
More information
The U.S. Centers for Disease Control and Prevention has more on avian flu.
Source: HealthDay
